Marginating Dendritic Cells of the Tumor Microenvironment Cross-Present Tumor Antigens and Stably Engage Tumor-Specific T Cells
- 1 March 2012
- journal article
- Published by Elsevier in Cancer Cell
- Vol. 21 (3) , 402-417
Abstract
No abstract availableKeywords
Funding Information
- Cancer Research Institute
- EMBO (CA108462)
- National Institutes of Health (R01CA129523, R01CA134622, U01CA141451)
This publication has 50 references indexed in Scilit:
- Treating cancer with genetically engineered T cellsTrends in Biotechnology, 2011
- Switch-based biosensors: a new approach towards real-time, in vivo molecular detectionTrends in Biotechnology, 2011
- Macrophage Diversity Enhances Tumor Progression and MetastasisCell, 2010
- CD4+ T Cells Regulate Pulmonary Metastasis of Mammary Carcinomas by Enhancing Protumor Properties of MacrophagesCancer Cell, 2009
- Trophic macrophages in development and diseaseNature Reviews Immunology, 2009
- Myeloid-derived suppressor cells as regulators of the immune systemNature Reviews Immunology, 2009
- Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancerNature Medicine, 2007
- Adoptive immunotherapy for cancer: building on successNature Reviews Immunology, 2006
- Visualizing dendritic cell networks in vivoNature Immunology, 2004
- Serial triggering of many T-cell receptors by a few peptide–MHC complexesNature, 1995